Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 252

1.

Filling and refilling practices with diazepam and methyldopa.

Scrivens JJ Jr, Weber C Jr, Sather M, Geck W.

Hosp Formul. 1979 Sep;14(9):830-1,834-6,838. No abstract available.

PMID:
10243909
2.

Managing the hospital pharmacy. Interview by Nancy M. Agresta.

Lantos RL.

Hosp Formul. 1979 Sep;14(9):839-43. No abstract available.

PMID:
10243910
3.

Procedure for evaluating nonformulary drug orders.

Jay GT, Quercia RA, Gousse G, Chow MS, Quintiliani R.

Am J Hosp Pharm. 1993 Dec;50(12):2554-6. No abstract available.

PMID:
8122692
4.

Development and implementation of a comprehensive, criteria-based drug-use review program.

Todd MW, Keith TD, Foster MT Jr.

Am J Hosp Pharm. 1987 Mar;44(3):529-35.

PMID:
3471089
5.

Antibiotic review performed by a pharmacy and therapeutics subcommittee.

Klapp DL, Ramphal R.

QRB Qual Rev Bull. 1982 Jan;8(1):15-9. No abstract available.

PMID:
6803205
6.

Use of criteria developed before formulary addition to evaluate misoprostol use.

Rice KM, LeRoy ML, Ivey MF, Deck C, Krstenansky P.

Am J Hosp Pharm. 1992 Mar;49(3):629-31. No abstract available.

PMID:
1598943
7.

Pharmacy U.R. cuts costs, drug use.

Mosier RL.

Hosp Peer Rev. 1979 May;4(5):70-2. No abstract available.

PMID:
10308905
8.
9.

Concurrent antibiotic-use review in a small hospital.

Kerns MP, Meyer GE.

Am J Hosp Pharm. 1986 Jun;43(6):1476-8.

PMID:
3728483
10.

Antibiotic review: the experience of one pharmacy and therapeutics committee.

Kiepert DR Jr.

QRB Qual Rev Bull. 1979 Jan;5(1):24-7. No abstract available.

PMID:
121376
11.

Prescriber identification program.

Frighetto L, Bunz D, Jewesson P.

Can J Hosp Pharm. 1991 Feb;44(1):35-6. No abstract available.

PMID:
10110042
12.

An integrated drug use evaluation program.

Lazor-Bajcar J, Fowler R.

Dimens Health Serv. 1990 Nov;67(8):17-20. No abstract available.

PMID:
2276521
13.

Pharmacist adjustment of H2-receptor antagonist dosage to meet medical staff-approved criteria.

Malcolm KE, Griffin CR, Bennett TA, Robertson LM.

Am J Hosp Pharm. 1994 Sep 1;51(17):2152-4. No abstract available.

PMID:
7985692
14.

Hospital restriction policy for newly marketed antimicrobial agents.

Jeffrey LP, McCloskey WW, Rich DS, Mahoney CD.

Am J Hosp Pharm. 1986 Sep;43(9):2230-2. No abstract available.

PMID:
3766580
15.

ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.

Pedersen CA, Schneider PJ, Scheckelhoff DJ.

Am J Health Syst Pharm. 2005 Feb 15;62(4):378-90.

PMID:
15745890
16.

Monitoring theophylline therapy to prevent toxicity.

Lubischer AV, Lucas LM.

Am J Health Syst Pharm. 1996 Jun 1;53(11):1292-4. No abstract available.

PMID:
8725203
17.

Achieving rational therapeutics through consensus-based protocols and follow-up.

Quintiliani R, Gousse GC, Chow MS.

Hosp Formul. 1990 Mar;25(3):283-4, 289-94.

PMID:
10103836
18.

An approach to regulating cephalosporin use and costs.

Ryan JL, Francese J Jr.

Hosp Formul. 1980 Sep;15(9):674-6. No abstract available.

PMID:
10248357
19.

[Drug committees in Denmark. Status and future challenges].

Rabøl R, Kampmann JP, Christensen HR.

Ugeskr Laeger. 2004 Aug 23;166(35):2988-91. Danish. No abstract available.

PMID:
15387009
20.

[Safer drug handling in hospitals. A new task for the drug committee].

Osterman PO, Gyllenspetz L, Hartvig P, Levol R, Rane A, Söderström A.

Lakartidningen. 1996 Oct 30;93(44):3917-20. Swedish. No abstract available.

PMID:
8965581

Supplemental Content

Support Center